BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22825128)

  • 1. Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells.
    Wei J; Liu H; Liu M; Wu N; Zhao J; Xiao L; Han L; Chu E; Lin X
    Oncol Rep; 2012 Oct; 28(4):1339-45. PubMed ID: 22825128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells.
    Wei J; Liu M; Liu H; Wang H; Wang F; Zhang Y; Han L; Lin X
    J Appl Toxicol; 2013 Aug; 33(8):756-65. PubMed ID: 22678527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells.
    Yeung BH; Huang DC; Sinicrope FA
    J Biol Chem; 2006 Apr; 281(17):11923-32. PubMed ID: 16446371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ellagic acid on chemosensitivity to 5-fluorouracil in colorectal carcinoma cells.
    Kao TY; Chung YC; Hou YC; Tsai YW; Chen CH; Chang HP; Chou JL; Hsu CP
    Anticancer Res; 2012 Oct; 32(10):4413-8. PubMed ID: 23060566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
    Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW
    Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
    Huang Z; Guo KJ; Guo RX; He SG
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine.
    Boya P; Gonzalez-Polo RA; Poncet D; Andreau K; Vieira HL; Roumier T; Perfettini JL; Kroemer G
    Oncogene; 2003 Jun; 22(25):3927-36. PubMed ID: 12813466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
    Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
    Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of induction of apoptosis by sequential treatment with cisplatin followed by 5-fluorouracil in human oral cancer cells.
    Azuma M; Harada K; Supriatno ; Tamatani T; Motegi K; Ashida Y; Sato M
    Int J Oncol; 2004 Jun; 24(6):1449-55. PubMed ID: 15138587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP.
    Shyu MH; Kao TC; Yen GC
    J Agric Food Chem; 2010 May; 58(10):6110-8. PubMed ID: 20415421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
    Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway.
    von Haefen C; Gillissen B; Hemmati PG; Wendt J; Güner D; Mrozek A; Belka C; Dörken B; Daniel PT
    Oncogene; 2004 Oct; 23(50):8320-32. PubMed ID: 15467752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
    Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
    Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.